Exelixis
The Senior Scientist I, Analytical Development, Biologics CMC supports the analytical development of biologic therapeutics by establishing and advancing phase-appropriate cell-based bioassays, potency, functional, and binding assay capabilities. This hands-on role independently develops, optimizes, qualifies, transfers, and manages fit-for-purpose assays that reflect product mechanism of action and critical quality attributes across various biologic modalities. The position ensures scientifically rigorous, regulatory-relevant, cost-effective, and timely potency assay strategies through strong laboratory execution and cross-functional collaboration.
Headquarters
Alameda, California, United States
Company Size
1001-5000 employees
Founded
1994
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Exelixis.
Exelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Scientist, Analytical Cell Line Engineering & Bioassay Development
BioLife Plasma Services
Research Associate, Analytical Development
Moderna
Senior Scientist 1, Bioassay Development, CMC Biologics, Analytical Research & Development
AbbVie
Senior Scientist, Analytical Development
Eurofins
Technical Development
Moderna
Senior Scientist, Analytical Development
Eurofins